HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: M500417-JLR200v1 47/1/201    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lee, H. Articles by Edwards, P. A. Search for Related Content PubMed PubMed Citation Articles by Lee, H. Articles by Edwards, P. A. Social Bookmarking                      What's this?

Journal of Lipid Research, Vol. 47, 201-214, January 2006
Copyright © 2006 by American Society for Biochemistry and Molecular Biology

FXR regulates organic solute transporters and ß in the adrenal gland, kidney, and intestine

Hans Lee^*, Yanqiao Zhang^*, Florence Y. Lee^*, Stanley F. Nelson, Frank J. Gonzalez and Peter A. Edwards^1,*,**

^* Department of Biological Chemistry and Medicine, University of California, Los Angeles, Los Angeles, CA 90095
Department of Human Genetics, University of California, Los Angeles, Los Angeles, CA 90095
^** Molecular Biology Institute, University of California, Los Angeles, Los Angeles, CA 90095
Laboratory of Metabolism, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892

Published, JLR Papers in Press, October 26, 2005.

¹ To whom correspondence should be addressed. e-mail: pedwards{at}mednet.ucla.edu

Expression of the farnesoid X receptor (FXR; NR1H4) is limited to the liver, intestine, kidney, and adrenal gland. However, the role of FXR in the latter two organs is unknown. In the current study, we performed microarray analysis using RNA from H295R cells infected with constitutively active FXR. Several putative FXR target genes were identified, including the organic solute transporters and ß (OST and OSTß). Electromobility shift assays and promoter-reporter studies identified functional farnesoid X receptor response elements (FXREs) in the promoters of both human genes. These FXREs are conserved in both mouse genes. Treatment of wild-type mice with 3-(2,6-dichlorophenyl)-4-(3'-carboxy-2-chloro-stilben-4-yl)-oxymethyl-5-isopropyl-isoxazole (GW4064), a synthetic FXR agonist, induced OST and OSTß mRNAs in the intestine and kidney. Both mRNAs were also induced when wild-type, but not FXR-deficient (FXR^–/–), adrenals were cultured in the presence of GW4064. OST and OSTß mRNA levels were also induced in the adrenals and kidneys of wild-type, but not FXR^–/–, mice after the increase of plasma bile acids in response to the hepatotoxin -naphthylisothiocyanate. Finally, overexpression of human OST and OSTß facilitated the uptake of conjugated chenodeoxycholate and the activation of FXR target genes. These results demonstrate that OST and OSTß are novel FXR target genes that are expressed in the adrenal gland, kidney, and intestine.—Lee, H., Y. Zhang, F. Y. Lee, S. F. Nelson, F. J. Gonzalez, and P. A. Edwards. FXR regulates organic solute transporters and ß in the adrenal gland, kidney, and intestine.

Supplementary key words farnesoid X receptor • chenodeoxycholic acid • 3-(2,6-dichlorophenyl)-4-(3'carboxy-2-chloro-stilben-4-yl)-oxymethyl-5-isopropyl-isoxazole

Abbreviations: ANIT, -naphthylisothiocyanate; ASBT, apical sodium-dependent bile acid transporter; BSEP, bile salt export pump; CDCA, chenodeoxycholic acid; FGF-19, fibroblast growth factor 19; FXR, farnesoid X receptor; FXRE, farnesoid X receptor response element; GFP, green fluorescent protein; GW4064, 3-(2,6-dichlorophenyl)-4-(3'-carboxy-2-chloro-stilben-4-yl)-oxymethyl-5-isopropyl-isoxazole; I-BABP, ileal bile acid binding protein; MRP2, multidrug resistance-related protein 2; OST and OSTß, organic solute transporters and ß; PLTP, phospholipid transfer protein; RXR, 9-cis retinoic acid receptor ; SHP, small heterodimer partner

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				R. R.M. Maran, A. Thomas, M. Roth, Z. Sheng, N. Esterly, D. Pinson, X. Gao, Y. Zhang, V. Ganapathy, F. J. Gonzalez, et al. Farnesoid X Receptor Deficiency in Mice Leads to Increased Intestinal Epithelial Cell Proliferation and Tumor Development J. Pharmacol. Exp. Ther., February 1, 2009; 328(2): 469 - 477. [Abstract] [Full Text] [PDF]

				J. J. Eloranta and G. A. Kullak-Ublick The Role of FXR in Disorders of Bile Acid Homeostasis Physiology, October 1, 2008; 23(5): 286 - 295. [Abstract] [Full Text] [PDF]

				N. Ballatori, F. Fang, W. V. Christian, N. Li, and C. L. Hammond Ost{alpha}-Ost{beta} is required for bile acid and conjugated steroid disposition in the intestine, kidney, and liver Am J Physiol Gastrointest Liver Physiol, July 1, 2008; 295(1): G179 - G186. [Abstract] [Full Text] [PDF]

				A. Rao, J. Haywood, A. L. Craddock, M. G. Belinsky, G. D. Kruh, and P. A. Dawson The organic solute transporter {alpha}-{beta}, Ost{alpha}-Ost{beta}, is essential for intestinal bile acid transport and homeostasis PNAS, March 11, 2008; 105(10): 3891 - 3896. [Abstract] [Full Text] [PDF]

				I. Kim, S.-H. Ahn, T. Inagaki, M. Choi, S. Ito, G. L. Guo, S. A. Kliewer, and F. J. Gonzalez Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine J. Lipid Res., December 1, 2007; 48(12): 2664 - 2672. [Abstract] [Full Text] [PDF]

				H. Lee, M. L. Hubbert, T. F. Osborne, K. Woodford, N. Zerangue, and P. A. Edwards Regulation of the Sodium/Sulfate Co-transporter by Farnesoid X Receptor {alpha} J. Biol. Chem., July 27, 2007; 282(30): 21653 - 21661. [Abstract] [Full Text] [PDF]

				S. M. Houten, D. H. Volle, C. L. Cummins, D. J. Mangelsdorf, and J. Auwerx In Vivo Imaging of Farnesoid X Receptor Activity Reveals the Ileum as the Primary Bile Acid Signaling Tissue Mol. Endocrinol., June 1, 2007; 21(6): 1312 - 1323. [Abstract] [Full Text] [PDF]

				M. L. Hubbert, Y. Zhang, F. Y. Lee, and P. A. Edwards Regulation of Hepatic Insig-2 by the Farnesoid X Receptor Mol. Endocrinol., June 1, 2007; 21(6): 1359 - 1369. [Abstract] [Full Text] [PDF]

				J. L. Boyer, M. Trauner, A. Mennone, C. J. Soroka, S.-Y. Cai, T. Moustafa, G. Zollner, J. Y. Lee, and N. Ballatori Upregulation of a basolateral FXR-dependent bile acid efflux transporter OST{alpha}-OSTbeta in cholestasis in humans and rodents Am J Physiol Gastrointest Liver Physiol, June 1, 2006; 290(6): G1124 - G1130. [Abstract] [Full Text] [PDF]